Cited by 84Pain Mechanisms and TreatmentsPain Management and TreatmentMusculoskeletal pain and rehabilitation

Sensory symptom profiles and co-morbidities in painful radiculopathy

Open access
Mahn, Friederike, Hüllemann, Philipp, Gockel, Ulrich, Brosz, Mathias, Freynhagen, Rainer, Tölle, Thomas R., Baron, Ralf·2011·PLoS ONE

Abstract

Painful radiculopathies (RAD) and classical neuropathic pain syndromes (painful diabetic polyneuropathy, postherpetic neuralgia) show differences how the patients express their sensory perceptions. Furthermore, several clinical trials with neuropathic pain medications failed in painful radiculopathy. Epidemiological and clinical data of 2094 patients with painful radiculopathy were collected within a cross sectional survey (painDETECT) to describe demographic data and co-morbidities and to detect characteristic sensory abnormalities in patients with RAD and compare them with other neuropathic pain syndromes. Common co-morbidities in neuropathic pain (depression, sleep disturbance, anxiety) do not differ considerably between the three conditions. Compared to other neuropathic pain syndromes touch-evoked allodynia and thermal hyperalgesia are relatively uncommon in RAD. One distinct sensory symptom pattern (sensory profile), i.e., severe painful attacks and pressure induced pain in combination with mild spontaneous pain, mild mechanical allodynia and thermal hyperalgesia, was found to be characteristic for RAD. Despite similarities in sensory symptoms there are two important differences between RAD and other neuropathic pain disorders: (1) The paucity of mechanical allodynia and thermal hyperalgesia might be explained by the fact that the site of the nerve lesion in RAD is often located proximal to the dorsal root ganglion. (2) The distinct sensory profile found in RAD might be explained by compression-induced ectopic discharges from a dorsal root and not necessarily by nerve damage. These differences in pathogenesis might explain why medications effective in DPN and PHN failed to demonstrate efficacy in RAD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0018018

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The greater refractoriness of HIV-related neuropathy and radiculopathy may be due to large placebo responses, a distinct clinical phenotype, or neglected psychosocial comorbidities.

    “This may be due to large placebo responses in HIV-related neuropathy trials,45 a distinct clinical phenotype in subgroups of patients with radiculopathy,46 or psychological/psychosocial comorbidites, often neglected in large trials.”
  • Placebo response is higher in HIV-related neuropathies and in patients with low or variable baseline pain scores, and lower in postherpetic neuralgia.

    “Placebo response has been found to be higher in HIV-related neuropathies,45 and in patients with low or variable pain scores at inclusion.52 Conversely it seems to be lower in postherpetic neuralgia.45”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mahn, F., Hüllemann, P., Gockel, U., Brosz, M., Freynhagen, R., Tölle, T. R., & Baron, R.
Affiliations
  • University Hospital Schleswig-Holstein (DE)
  • Technical University of Munich (DE)
Corresponding author
Baron, Ralf
Venue
PLoS ONE
Published
2011-05-09
Volume
6
Issue
5
Pages
e18018
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2158273944
Cited by
84
References
25
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 6 · 2022: 6 · 2021: 7 · 2020: 8 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 5 · 2012: 4
FWCI
4.36
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • mediaTUM (Technical University of Munich) (submittedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • Sanofi
  • Eisai
  • Astellas Pharma
  • Allergan
  • UCB US
  • Sanofi Pasteur
  • UCB Pharma
Topics
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Medicine › Pharmacology › Musculoskeletal pain and rehabilitation
Keywords
neuropathic pain, diabetic polyneuropathy, postherpetic neuralgia, mechanical allodynia, thermal hyperalgesia, depression, sleep disorders, anxiety, comorbidities, dorsal root ganglia, ectopic discharges, painDETECT
MeSH terms
Aged, Female, Humans, Male, Middle Aged, Neuralgia, Radiculopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review